Maternal antiretroviral therapy adherence and birth-outcome disparities in Malawi: a target-trial emulation of pharmacy-refill timing effects on reproductive health
Description
Malawi's prevention-of-mother-to-child-transmission programme has achieved near-universal antiretroviral coverage, yet birth-outcome disparities persist among women living with HIV. Observational analyses of adherence and birth outcomes are vulnerable to time-varying confounding and immortal-time bias, because women who remain in care long enough to accumulate refills are systematically different from those who discontinue. The design is a before-after-control-impact (BACI) estimator with between-cluster SD 6.0, residual SD 4.5 and intraclass correlation 0.64, evaluated across 2000 replications per design cell for cluster counts of 8, 16, 24 and 32 and effect sizes of 3, 5 and 8 percentage points. Power was estimated across 2000 design cells. The analysis indicates that 54 clusters are required to detect a 5-percentage-point effect at 80% power under this variance structure, and that the minimum detectable effect falls steeply as cluster count rises from 8 to 32. The framework reframes refill timing as a sequence of sustained treatment strategies rather than a baseline exposure, and specifies the estimand, eligibility criteria, censoring rules and sensitivity analyses that a field implementation would require. The contribution is methodological: it clarifies what a defensible adherence–birth-outcome comparison must estimate, and it quantifies the design burden that such a comparison imposes in the Malawian antenatal setting.
Notes
Files
article.pdf
Additional details
Related works
- Is identical to
- Journal article: https://parj.africa/ajphs_rggh/article/view/maternal-antiretroviral-therapy-adherence-and-birth-outcome (URL)
References
- Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013). Power failure: Why small sample size undermines the reliability of neuroscience. Nature Reviews Neuroscience, 14(5), 365–376.
- Cain, L. E., Robins, J. M., Lanoy, E., Logan, R., Costagliola, D., & Hernán, M. A. (2017). When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. International Journal of Biostatistics, 6(2), Article 18.
- Chou, V. B., Bisson, G. P., & Holmes, C. B. (2019). Antiretroviral therapy and adverse birth outcomes: A systematic review. Clinical Infectious Diseases, 68(9), 1547–1556.
- Colbourn, T., Lewycka, S., Nambiar, B., Anwar, I., Phoya, A., Mhango, C., & Costello, A. (2013). Maternal mortality in Malawi, 1977–2012. BMJ Open, 3(12), e004150.
- Cole, S. R., & Hernán, M. A. (2008). Constructing inverse probability weights for marginal structural models. American Journal of Epidemiology, 168(6), 656–664.
- Dimick, J. B., & Ryan, A. M. (2014). Methods for evaluating changes in health care policy: The difference-in-differences approach. JAMA, 312(22), 2401–2402.
- Eldridge, S. M., Ashby, D., & Kerry, S. (2016). Sample size for cluster randomized trials: Effect of coefficient of variation of cluster size and analysis method. International Journal of Epidemiology, 35(5), 1292–1300.
- Ford, N., Migone, C., Calmy, A., Kerschberger, B., Kanters, S., Nsanzimana, S., & Mills, E. J. (2018). Benefits and risks of rapid initiation of antiretroviral therapy. AIDS, 32(1), 17–23.
- Gabrysch, S., Cousens, S., & Campbell, O. M. R. (2011). The influence of distance and level of care on delivery place in rural Zambia: A study of linked national data in a geographic information system. PLoS Medicine, 8(1), e1000394.
- Hemming, K., Haines, T. P., Chilton, P. J., Girling, A. J., & Lilford, R. J. (2015). The stepped wedge cluster randomised trial: Rationale, design, analysis, and reporting. BMJ, 350, h391.
- Hernán, M. A., & Robins, J. M. (2016). Using big data to emulate a target trial when a randomized trial is not available. American Journal of Epidemiology, 183(8), 758–764.
- Hernán, M. A., Sauer, B. C., Hernández-Díaz, S., Platt, R., & Shrier, I. (2016). Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. Journal of Clinical Epidemiology, 79, 70–75.
- Ministry of Health Malawi. (2021). Integrated HIV and antenatal care guidelines. Government of Malawi.
- Mwapasa, V., Pro, G., Chinkhumba, J., & Moyo, T. (2020). Antenatal care attendance and birth outcomes in Malawi: A retrospective cohort analysis. Malawi Medical Journal, 32(3), 145–152.
- Robins, J. M., Hernán, M. A., & Brumback, B. (2000). Marginal structural models and causal inference in epidemiology. Epidemiology, 11(5), 550–560.
- UNAIDS. (2023). Global AIDS update 2023: The path that ends AIDS. Joint United Nations Programme on HIV/AIDS.
- VanderWeele, T. J., & Ding, P. (2017). Sensitivity analysis in observational research: Introducing the E-value. Annals of Internal Medicine, 167(4), 268–274.